|1.||Maupin, Kevin A: 3 articles (07/2012 - 01/2011)|
|2.||Brand, Randall E: 3 articles (07/2012 - 01/2011)|
|3.||Partyka, Katie: 3 articles (07/2012 - 01/2011)|
|4.||Haab, Brian B: 3 articles (07/2012 - 01/2011)|
|5.||Moser, A James: 3 articles (09/2011 - 11/2010)|
|6.||Chiara, Giordano B: 2 articles (11/2014 - 03/2012)|
|7.||Lumachi, Franco: 2 articles (11/2014 - 03/2012)|
|8.||Basso, Stefano M M: 2 articles (11/2014 - 03/2012)|
|9.||Yamaue, Hiroki: 2 articles (09/2014 - 05/2011)|
|10.||Lee, Jeffrey E: 2 articles (05/2014 - 07/2010)|
02/01/2015 - "Serum tumor marker studies revealed elevated carbohydrate antigen (CA) 19-9. Therefore, the tumor was considered to have malignant potential, and surgical resection was performed. "
10/01/2006 - "The aim of the study was to assess the utility of 2 neoplastic markers, cancer antigen (CA) 19-9 and CA 125, in the differential diagnosis of pancreatic tumors. "
07/01/2004 - "Further studies would be necessary to support the addition to this list, of other tests [e.g., cancer antigen (CA) 19-9]. "
05/01/2001 - "Visual analysis of PET images were correlated with the results of abdominal computed tomography (CT) and carbohydrate antigen (CA) 19-9 serum tumor marker level that were obtained within 1 month of the PET study. "
11/01/1982 - "The successful use of the IP assay on fixed tissue to demonstrate the specific sites of gastrointestinal cancer antigen localization in human tumors and normal tissues provides an important tool for the study of developing neoplasia."
|2.||Pancreatic Neoplasms (Pancreatic Cancer)
10/28/2014 - "To develop a method to differentiate pancreatic cancer patients from healthy or benign individuals when carbohydrate antigen (CA) 19-9 is normal. "
07/01/2012 - "The CA 19-9 antigen is currently the best individual marker for the detection of pancreatic cancer. "
08/01/2011 - "CA 19-9 antigen, routinely used in the monitoring of pancreatic cancer, also has been detected in the tissue of approximately 6% of MTCs. "
01/01/2008 - "Gastrointestinal cancer antigen CA19-9 is known as a valuable marker for the management of patients with pancreatic cancer. "
01/01/2006 - "Serum levels of carbohydrate antigen (CA) 19-9 have long been employed as a biomarker in diagnosing pancreatic cancer in symptomatic patients. "
11/01/1994 - "[Is the carbohydrate antigen Ca 19.9 useful in the diagnosis of pancreatic carcinoma?]."
07/01/1992 - "Grade 3 and pT1, pT2/pT3 carcinomas showed a constant staining for CA 19-9 antigen, grade 2 showed a 50% positive immunoreaction while all grade 1 cases were negative. "
04/01/1991 - "Antigen CA 19-9: presence in mucosa of nondiseased müllerian duct derivatives and marker for differentiation in their carcinomas."
05/01/1989 - "The diagnostic significance of carbohydrate antigen CA 19-9 in serum and pancreatic juice in pancreatic carcinoma."
05/01/1989 - "Of 25 follicular carcinomas, 15 gave a positive staining for the CA 50 and 6 for the CA 19-9 antigen. "
|4.||Stomach Neoplasms (Stomach Cancer)
01/01/2015 - "The clinical value of carbohydrate antigen (CA) 19-9 in gastric cancer is controversial. "
01/01/1990 - "Detection of carbohydrate antigen (CA) 19-9 in tissues and sera was performed by an immunoperoxidase assay and by radioimmunoassay of samples from patients with gastric cancer. "
01/01/1986 - "The levels of the serum carbohydrate antigen (CA) 19-9 were assayed in 284 cases including 77 patients with gastric cancer. "
01/01/1986 - "[Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer]."
05/01/2010 - "The aim of this study was to evaluate the clinical significance of preoperative serum carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9 levels in resectable gastric cancer patients. "
|5.||Colorectal Neoplasms (Colorectal Cancer)
04/15/1996 - "The accumulation of CA 19-9 antigen in colorectal tumors might be caused mainly by the activation of alpha 2-->3sialyltransferase but not by that of alpha 1-->fucosyltransferase."
04/15/1996 - "Levels of alpha 2-->3sialyltransferase and alpha 1-->4fucosyltranferase activities and CA 19-9 antigen were measured in the extracts from colorectal tumors and their adjacent normal tissues. "
04/15/1996 - "A novel assay method specific for alpha 2-->3sialyltransferase that seems to be responsible for the synthesis of CA 19-9 antigen was developed and the levels of the enzyme in colorectal tumor tissues were measured and compared with the levels of alpha 1-->4fucosyltransferase and the CA 19-9 antigen. "
11/01/1994 - "The prognostic information provided by preoperative serum CEA and CA 19.9 antigen assay on the postoperative outcome of 150 patients with colorectal cancer was analysed. "
07/01/1997 - "The prognostic information provided by preoperative serum CEA, CA 19-9 antigen assays as compared with the classical prognostic factors (age, sex, tumor infiltration, tumor stage (Dukes') and R-classification) in 495 patients with colorectal carcinoma was analysed. "
|2.||Biological Tumor Markers (Tumor Markers)
|4.||Intercellular Signaling Peptides and Proteins (Growth Factors)
|7.||Neoplasm Antigens (Tumor Antigens)
|9.||CA-125 Antigen (CA 125 Antigen)
|10.||Prostate-Specific Antigen (Semenogelase)
|1.||Drug Therapy (Chemotherapy)
|3.||Renal Dialysis (Hemodialysis)